CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY)
Clinical trials for CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY) explained in plain language.
Never miss a new study
Get alerted when new CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY) trials appear
Sign up with your email to follow new studies for CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks Real-Life impact of CIDP drug on 200 patients
Disease control Recruiting nowThis study follows 200 adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are starting treatment with efgartigimod. Researchers will track changes in disability, grip strength, and quality of life over two years to see how well the drug works in real…
Matched conditions: CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY)
Sponsor: argenx • Aim: Disease control
Last updated May 17, 2026 17:09 UTC
-
New shot option for nerve disease? study tests weekly vs IV treatment
Disease control Recruiting nowThis study compares two medicines for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), a nerve disorder. It aims to see if XEMBIFY, given as a weekly shot under the skin, provides similar drug levels as Gamunex-C, given into a vein every 3 weeks. About 40 adults …
Matched conditions: CIDP (CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY)
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC